Year |
Citation |
Score |
2016 |
Getlik M, Smil D, Zepeda-Velázquez C, Bolshan Y, Poda G, Wu H, Dong A, Kuznetsova E, Marcellus R, Senisterra G, Dombrovski L, Hajian T, Kiyota T, Schapira M, Arrowsmith CH, et al. Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1). Journal of Medicinal Chemistry. PMID 26958703 DOI: 10.1021/Acs.Jmedchem.5B01630 |
0.695 |
|
2015 |
Baxter M, Bolshan Y. A General Access to Propargylic Ethers through Brønsted Acid Catalyzed Alkynylation of Acetals and Ketals with Trifluoroborates . Chemistry (Weinheim An Der Bergstrasse, Germany). 21: 13535-8. PMID 26248543 DOI: 10.1002/Chem.201502797 |
0.301 |
|
2015 |
Taylor CL, Bolshan Y. Metal-free synthesis of ynones from acyl chlorides and potassium alkynyltrifluoroborate salts. Journal of Visualized Experiments : Jove. PMID 25742169 DOI: 10.3791/52401 |
0.321 |
|
2015 |
Taylor C, Bolshan Y. Metal-free methodology for the preparation of sterically hindered alkynoylphenols and its application to the synthesis of flavones and aurones Tetrahedron Letters. 56: 4392-4396. DOI: 10.1016/J.Tetlet.2015.05.097 |
0.326 |
|
2014 |
Al-Awar R, Al-Awar R, Getlik M, Smil D, Bolshan Y, Poda G, Senisterra G, Wu H, Allali-Hassani A, Wasney G, Barsyte-Lovejoy D, Dombrovski L, Dong A, He H, Seitova A, et al. 287 The discovery and optimization of small molecule antagonists of the WDR5–MLL interaction European Journal of Cancer. 50: 95. DOI: 10.1016/S0959-8049(14)70413-7 |
0.622 |
|
2013 |
Bolshan Y, Getlik M, Kuznetsova E, Wasney GA, Hajian T, Poda G, Nguyen KT, Wu H, Dombrovski L, Dong A, Senisterra G, Schapira M, Arrowsmith CH, Brown PJ, Al-Awar R, et al. Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction. Acs Medicinal Chemistry Letters. 4: 353-7. PMID 24900672 DOI: 10.1021/Ml300467N |
0.699 |
|
2013 |
Li B, Tempel W, Smil D, Bolshan Y, Schapira M, Park HW. Crystal structures of Klebsiella pneumoniae pantothenate kinase in complex with N-substituted pantothenamides. Proteins. 81: 1466-72. PMID 23553820 DOI: 10.1002/Prot.24290 |
0.633 |
|
2013 |
Yu W, Smil D, Li F, Tempel W, Fedorov O, Nguyen KT, Bolshan Y, Al-Awar R, Knapp S, Arrowsmith CH, Vedadi M, Brown PJ, Schapira M. Bromo-deaza-SAH: a potent and selective DOT1L inhibitor. Bioorganic & Medicinal Chemistry. 21: 1787-94. PMID 23433670 DOI: 10.1016/J.Bmc.2013.01.049 |
0.663 |
|
2013 |
Bullwinkle TJ, Zou SB, Rajkovic A, Hersch SJ, Elgamal S, Robinson N, Smil D, Bolshan Y, Navarre WW, Ibba M. (R)-β-lysine-modified elongation factor P functions in translation elongation. The Journal of Biological Chemistry. 288: 4416-23. PMID 23277358 DOI: 10.1074/Jbc.M112.438879 |
0.603 |
|
2013 |
Senisterra G, Wu H, Allali-Hassani A, Wasney GA, Barsyte-Lovejoy D, Dombrovski L, Dong A, Nguyen KT, Smil D, Bolshan Y, Hajian T, He H, Seitova A, Chau I, Li F, et al. Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5. The Biochemical Journal. 449: 151-9. PMID 22989411 DOI: 10.1042/Bj20121280 |
0.677 |
|
2012 |
Siarheyeva A, Senisterra G, Allali-Hassani A, Dong A, Dobrovetsky E, Wasney GA, Chau I, Marcellus R, Hajian T, Liu F, Korboukh I, Smil D, Bolshan Y, Min J, Wu H, et al. An allosteric inhibitor of protein arginine methyltransferase 3. Structure (London, England : 1993). 20: 1425-35. PMID 22795084 DOI: 10.1016/J.Str.2012.06.001 |
0.661 |
|
2008 |
Bolshan Y, Batey RA. Enamide synthesis by copper-catalyzed cross-coupling of amides and potassium alkenyltrifluoroborate salts. Angewandte Chemie (International Ed. in English). 47: 2109-12. PMID 18236496 DOI: 10.1002/Anie.200704711 |
0.503 |
|
2005 |
Bolshan Y, Batey RA. A room-temperature protocol for the rhodium(I)-catalyzed addition of arylboron compounds to sulfinimines. Organic Letters. 7: 1481-4. PMID 15816732 DOI: 10.1021/Ol050014F |
0.536 |
|
Show low-probability matches. |